Preview
Objectives: To determine whether voriconazole dosage adjustment is required during continuous veno-venous haemodiafiltration (CVVHDF).
Methods: Voriconazole pharmacokinetics were studied in a critically ill patient under CVVHDF. The analysis was carried out for 12 h following a 6 mg/kg dose. Voriconazole concentrations were measured by HPLC in blood inlet and outlet lines and in dialysate.
Results: The total body clearance of voriconazole was 20.3 L/h, with a terminal half-life of 13.7 h and a distribution volume of 399 L. The estimated sieving coefficient was 0.53 and the filtration-dialysis clearance 1.2 L/h.
Conclusions: CVVHDF does not significantly affect voriconazole disposition and requires no dosage adjustment.
Keywords: antifungals; renal failure; dialysis; pharmacokinetics
Journal Article. 1096 words. Illustrated.
Subjects: Medical Oncology ; Critical Care
Go to Oxford Journals » abstract
Full text: subscription required
How to subscribe Recommend to my Librarian
Users without a subscription are not able to see the full content. Please, subscribe or login to access all content.